Document Detail


Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.
MedLine Citation:
PMID:  21486961     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A high rate of resistance (49.5 to 72.7%) to amoxicillin (AMX) was observed in Helicobacter pylori after two or three unsuccessful eradication attempts. Unsuccessful eradication regimens significantly increase resistance to not only clarithromycin (CLR) and metronidazole (MNZ) but also AMX.
Authors:
Toshihiro Nishizawa; Hidekazu Suzuki; Hitoshi Tsugawa; Hiroe Muraoka; Juntaro Matsuzaki; Kenro Hirata; Fumiaki Ikeda; Masahiko Takahashi; Toshifumi Hibi
Publication Detail:
Type:  Journal Article     Date:  2011-04-12
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  55     ISSN:  1098-6596     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-19     Completed Date:  2011-09-14     Revised Date:  2013-03-15    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3012-4     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amoxicillin / therapeutic use*
Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Bacterial
Female
Helicobacter Infections / drug therapy*
Helicobacter pylori / drug effects*
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 26787-78-0/Amoxicillin
Comments/Corrections
Erratum In:
Antimicrob Agents Chemother. 2013 Feb;57(2):1106

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics and pharmacodynamics of TBR-652, a novel CCR5 antagonist, in HIV-1-infected, antire...
Next Document:  High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblasto...